GlassScriptPhysician profile
Noel Peterson
NPI 1891780763
$10,996.43
in general payments reported to CMS, 2019-2025
46 companies · $1,286 in 2025
The $1,286 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,802 · 2020: $2,153 · 2021: $1,944 · 2022: $1,418 · 2023: $1,385 · 2024: $1,009 · 2025: $1,286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,679.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,876.80 | 2019-2025 | Brilinta, Wainua, Farxiga |
| Boston Scientific Corporation | $1,346.01 | 2019-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
| E.R. Squibb & Sons, L.L.C. | $1,022.45 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $891.42 | 2019-2025 | |
| Abbott Laboratories | $872.25 | 2019-2025 | Cardiomems, Mitraclip |
| Amgen INC. | $618.22 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $407.74 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $351.80 | 2019-2025 | Lifevest |
| Pfizer INC. | $330.80 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $239.07 | 2021-2025 | Verquvo, Capvaxive |
| Novo Nordisk INC | $229.55 | 2019-2025 | Wegovy, Ozempic |
| Janssen Pharmaceuticals, INC | $221.91 | 2019-2022 | |
| Amarin Pharma, INC. | $207.09 | 2019-2023 | |
| Biotronik INC. | $204.05 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.66 | 2019-2025 | Jardiance |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventric Diagnostics, INC. | $179.91 | 2022 | |
| Cvrx, INC. | $161.56 | 2022-2024 | Barostim Neo System |
| Akcea Therapeutics, INC. | $139.18 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $122.57 | 2019-2021 | |
| Baxter Healthcare | $103.51 | 2023 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Vifor Pharma, INC. | $96.98 | 2019-2021 | |
| Esperion Therapeutics, INC. | $94.12 | 2020-2021 | |
| Corvista Health, INC. | $90.37 | 2025 | Corvista System |
| Regeneron Healthcare Solutions, INC. | $88.13 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $82.35 | 2019-2022 | |
| Abiomed | $80.60 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.30 | 2024-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $74.15 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $66.31 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Gilead Sciences, INC. | $56.47 | 2019 | |
| Lundbeck LLC | $53.86 | 2019-2020 | |
| Medtronic, INC. | $48.81 | 2021-2024 | Corevalve Evolut R, Mycarelink |
| Chiesi USA, INC. | $48.67 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $45.71 | 2024-2025 | Onpattro |
| Scpharmaceuticals INC. | $39.21 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $33.08 | 2024 | |
| Irhythm Technologies, INC. | $29.59 | 2023 | Zio Xt Patch |
| Allergan, INC. | $26.78 | 2019 | |
| Astellas Pharma US INC | $26.12 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $20.73 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $19.54 | 2025 | Inspire |
| Genzyme Corporation | $16.37 | 2019 | |
| Cashflow Solutions, LLC | $15.85 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Bardy Diagnostics, INC. | $15.06 | 2022 | |
| Edwards Lifesciences Corporation | $13.86 | 2019 | |
| Glaxosmithkline, LLC. | $13.86 | 2025 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noel Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.